Literature DB >> 18080858

Viral outcome of simian-human immunodeficiency virus SHIV-89.6P adapted to cynomolgus monkeys.

A Borsetti1, S Baroncelli, M T Maggiorella, S Bellino, S Moretti, L Sernicola, R Belli, B Ridolfi, S Farcomeni, D R M Negri, A Cafaro, B Ensoli, F Titti.   

Abstract

Simian-human immunodeficiency virus (SHIV) 89.6P is considered to be one of the most pathogenic chimeric viruses in rhesus macaques. However, when crossing from one to another species of monkeys the pathogenicity of this virus may be affected. By using SHIV-89.6P(cy243), a virus obtained by passaging SHIV-89.6P in cynomolgus macaques, we investigated the dynamics of viral replication and the impact of the inoculum size (from 10 up to 50 monkey infectious dose) on the progression of the infection in 22 cynomolgus macaques. SHIV-89.6P(cy243 )caused massive depletion of CD4+ T-cells within 4 weeks of the inoculum, followed by an irreversible immune deficiency in a high proportion of the infected monkeys. This study demonstrates that SHIV-89.6P(cy243) is pathogenic in cynomolgus macaques and that the dynamics of the viral replication and the rate of clinical progression depend on the size of the inoculum. Our findings provide unique and relevant data, particularly with regard to the value of the in vivo titration used to select the most appropriate infectious dose to study the "virus-host" interplay.

Entities:  

Mesh:

Year:  2007        PMID: 18080858     DOI: 10.1007/s00705-007-0009-2

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  7 in total

1.  Mhc haplotype H6 is associated with sustained control of SIVmac251 infection in Mauritian cynomolgus macaques.

Authors:  Edward T Mee; Neil Berry; Claire Ham; Ulrike Sauermann; Maria T Maggiorella; Frédéric Martinon; Ernst J Verschoor; Jonathan L Heeney; Roger Le Grand; Fausto Titti; Neil Almond; Nicola J Rose
Journal:  Immunogenetics       Date:  2009-04-01       Impact factor: 2.846

Review 2.  Nonhuman primate models for the evaluation of HIV-1 preventive vaccine strategies: model parameter considerations and consequences.

Authors:  Gregory Q Del Prete; Jeffrey D Lifson; Brandon F Keele
Journal:  Curr Opin HIV AIDS       Date:  2016-11       Impact factor: 4.283

3.  Impact of viral dose and major histocompatibility complex class IB haplotype on viral outcome in mauritian cynomolgus monkeys vaccinated with Tat upon challenge with simian/human immunodeficiency virus SHIV89.6P.

Authors:  Aurelio Cafaro; Stefania Bellino; Fausto Titti; Maria Teresa Maggiorella; Leonardo Sernicola; Roger W Wiseman; David Venzon; Julie A Karl; David O'Connor; Paolo Monini; Marjorie Robert-Guroff; Barbara Ensoli
Journal:  J Virol       Date:  2010-06-16       Impact factor: 5.103

4.  The effect of early versus delayed challenge after vaccination in controlling SHIV 89.6P infection.

Authors:  Leslie L Chavez; Miles P Davenport; John W Shiver; Lynda G Tussey; Kara S Cox; Margaret Bachinsky; Fubao Wang; Lingyi Huang; William A Schleif; Mary-Ellen Davies; Aimin Tang; Danilo R Casimiro; Alan S Perelson; Ruy M Ribeiro
Journal:  Virology       Date:  2008-09-14       Impact factor: 3.616

5.  Biocompatible anionic polymeric microspheres as priming delivery system for effetive HIV/AIDS Tat-based vaccines.

Authors:  Fausto Titti; Maria T Maggiorella; Flavia Ferrantelli; Leonardo Sernicola; Stefania Bellino; Barbara Collacchi; Emanuele Fanales Belasio; Sonia Moretti; Maria Rosaria Pavone Cossut; Roberto Belli; Erika Olivieri; Stefania Farcomeni; Daniela Compagnoni; Zuleika Michelini; Michela Sabbatucci; Katia Sparnacci; Luisa Tondelli; Michele Laus; Aurelio Cafaro; Antonella Caputo; Barbara Ensoli
Journal:  PLoS One       Date:  2014-10-30       Impact factor: 3.240

6.  Effect of MHC haplotype on immune response upon experimental SHIVSF162P4cy infection of Mauritian cynomolgus macaques.

Authors:  Alessandra Borsetti; Flavia Ferrantelli; Maria T Maggiorella; Leonardo Sernicola; Stefania Bellino; Alessandra Gallinaro; Stefania Farcomeni; Edward T Mee; Nicola J Rose; Aurelio Cafaro; Fausto Titti; Barbara Ensoli
Journal:  PLoS One       Date:  2014-04-02       Impact factor: 3.240

7.  IL-7 receptor recovery on CD8 T-cells isolated from HIV+ patients is inhibited by the HIV Tat protein.

Authors:  Elliott M Faller; Mark J McVey; Paul A MacPherson
Journal:  PLoS One       Date:  2014-07-17       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.